Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis
Clinical trial NCT04521114 · COMPLETED
Trial details
- NCT number
- NCT04521114
- Sponsor
- CytoDyn, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2021-12-29
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.